Safety of TAS-102 in Patients With Metastatic Gastric/GE Junction and Colorectal Cancer
Lonsurf was well tolerated and associated with no major toxicities in two trials with 850 gastric cancer patients, said Cambridge doctor Lizzy Smyth.
Read Source